Previous close | 10.700 |
Open | 10.840 |
Bid | 11.000 x 0 |
Ask | 11.020 x 0 |
Day's range | 10.700 - 11.060 |
52-week range | 10.700 - 30.700 |
Volume | |
Avg. volume | 6,148,260 |
Market cap | 26.203B |
Beta (5Y monthly) | 0.95 |
PE ratio (TTM) | 4.94 |
EPS (TTM) | 2.230 |
Earnings date | 21 Aug 2024 - 26 Aug 2024 |
Forward dividend & yield | 0.80 (7.23%) |
Ex-dividend date | 26 Jun 2024 |
1y target est | 21.95 |
Amid a backdrop of fluctuating global markets, with the Hang Seng Index recently experiencing a notable decline, investors are increasingly focused on stable income streams. In this context, high-yield dividend stocks in Hong Kong, such as Dawnrays Pharmaceutical Holdings, offer potential for both income and diversification in uncertain times.
Amidst a backdrop of fluctuating global markets, the Hong Kong stock market has shown resilience, with the Hang Seng Index gaining 3.11% recently. This positive momentum in Hong Kong makes it an opportune time to examine dividend stocks, which can offer investors potential income stability and growth in varying economic climates.